HK Stock Market Move | Shandong Gold Mining (01787) rebounds over 4%; company lowers 2026 production guidance; institutions say performance is expected to grow strongly as production recovers.
Shandong Gold Mining (01787) rebounded over 4%. As of press time, it rose 4.26% to HK$19.32, with a turnover of HK$151 million.
Shandong Gold Mining (01787) rebounded over 4%. As of press time, it rose 4.26% to HK$19.32, with a turnover of HK$151 million.
On the news front, Shandong Gold Mining announced that the company has adjusted its 2026 production and operation plan, revising its planned mineral gold output from no less than 49 tonnes to 36-38 tonnes. The reasons for the adjustment include the impact on output from safety self-inspections triggered by industry safety accidents in the first half of the year, as well as increased efforts in domestic mine infrastructure construction in the second half.
BOCI said that after incorporating the company's updated production guidance, it lowered its 2026 core earnings per share forecast by 22%. Although the company currently expects a decline in net profit in 2026, as production returns to normal, performance is expected to achieve strong growth in 2027. The bank reiterated its "Buy" rating on Shandong Gold Mining and lowered its target price to HK$38.04.
Related Articles

HK Stock Market Move | SIMCERE PHARMA (02096) rose over 4% in early trading; SIM0660 recently licensed to Roche, TCE platform value validated again.

HK Stock Market Move | CANSINOBIO (06185) AH shares surge; the company's A-shares hit the daily limit; Moderna's ESMO data expectations boost the mRNA sector.

Founder: In this round of adjustments/quality supermarket expansion, what is new compared to the previous round of "new retail"?
HK Stock Market Move | SIMCERE PHARMA (02096) rose over 4% in early trading; SIM0660 recently licensed to Roche, TCE platform value validated again.

HK Stock Market Move | CANSINOBIO (06185) AH shares surge; the company's A-shares hit the daily limit; Moderna's ESMO data expectations boost the mRNA sector.

Founder: In this round of adjustments/quality supermarket expansion, what is new compared to the previous round of "new retail"?






